Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Pharmacol Biochem Behav. 2008 Oct;90(4):569–577. doi: 10.1016/j.pbb.2008.04.017

Figure 8. Antagonism of PCP treatment on PN7, 9, and 11-induced down-regulation on NR1 in the striatum.

Figure 8

Quantitative analysis reveals that pretreatment with olanzapine prevents PCP-induced (10 mg/kg, N=5–15/treatment) down-regulation of NR1 in the striatum. PCP treatment had no effect on protein levels of NR2A *p <0.05 vs. SAL NR1 (one-way ANOVA with Bonferroni's post hoc test)

HHS Vulnerability Disclosure